Prostate Cancer
Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis - Abstract
September 25, 2012
Tumour characteristics, oncological and functional outcomes in patients aged ≥ 70 years undergoing radical prostatectomy - Abstract
September 25, 2012
PSA testing in general practice - Abstract
September 25, 2012
Early diagnosis and treatment is crucial for neurological recovery after surgery for metastatic spinal cord compression in prostate cancer - Abstract
September 25, 2012
Denosumab for the treatment of cancer therapy-induced bone loss and prevention of skeletal-related events in patients with solid tumors - Abstract
September 25, 2012
African American prostate cancer survivors' treatment decision-making and quality of life - Abstract
September 24, 2012
Docetaxel in combination with estramustine and prednisolone for castration-resistant prostate cancer - Abstract
September 24, 2012
Family history of prostate cancer in a Black population - Abstract
September 24, 2012
Validity of the recorded codes of gonadotropin-releasing hormone agonist treatment and orchiectomies in the Danish National Patient Registry - Abstract
September 24, 2012
Diabetic nephropathy is associated with prostate-specific antigen levels in type 2 diabetes mellitus - Abstract
September 24, 2012
The impact of prostate biopsy on urinary symptoms, erectile function, and anxiety - Abstract
September 21, 2012
20-Year survival after radical prostatectomy as initial treatment for cT3 prostate cancer - Abstract
September 21, 2012
Comparative cost-effectiveness of stereotactic body radiation therapy versus intensity-modulated and proton radiation therapy for localized prostate cancer - Abstract
September 21, 2012
Review of hypofractionated radiotherapy for prostate cancer - Abstract
September 21, 2012